A front page WSJ story describes the commercial success of Actiq, a drug indicated for severe cancer pain. In my view it’s extremely important to have potent narcotics for people in this situation. Actiq is formulated as a lollipop, which makes it possible for people who can’t swallow to get relief.
The problem: people like lollipops, and Actiq is being prescribed for everything but what it’s indicated for. I’m worried that it might get taken off the market as a result.
Please, physicians, prescribe this drug wisely so we don’t lose it.November 3, 2006